|
|
|
10,001+ employees
View all
|
|
biotechnology
|
|
Marcy l'Etoile, Rhône-Alpes, FR
|
|
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors.
In 2019, revenues reached €2.7 billion, with over 90% of international sales.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
|
bioMérieux Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
81.53%
|
The widely used bioMérieux email format is {first}.{last} (e.g. [email protected]) with 81.53% adoption across the company.
To contact bioMérieux customer service number in your country click here to find.
Bob Woody is the CEO of bioMérieux. To contact Bob Woody email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.